In response to the COVID-19 public health emergency, rapid change was implemented across all levels of the London health and care system. Measures were implemented at pace and therefore engaging with the public on these was extremely challenging. As the NHS started planning its response to the next phase of the pandemic in the Capital, NHS England and Improvement (London region) wanted to explore Londoners’ expectations in relation to mid to longer-term measures and in particular the dilemmas and trade-offs these may create.
The deliberation aimed to understand Londoners’ expectations and to inform future decision-making relating to the response to the pandemic, specifically exploring the tensions and trade-offs. It culminated in the development of Londoners’ expectations, a set of guiding statements that are not binding, but rather are intended to assist the NHS when making decisions about services during the next phase of the pandemic.
A number of key themes emerged from the deliberation:
- There was an enormous sense of pride in the NHS and its staff. Participants understood the difficult challenges faced by the NHS and were keen to do what was needed to support it.
- In the context of the COVID-19 pandemic, participants were generally accepting of the need for change and the reduction of choice some of the measures discussed might result in.
- However, participants raised a number of concerns around the practicalities of how the different measures discussed during the workshops would be implemented.
- Key among these was how changes to services would affect different groups of people, particularly those considered more vulnerable. They wanted the NHS to show some flexibility and adaptability towards patients in vulnerable circumstances to avoid further exacerbating any existing inequalities.
- Participants felt safety and reassurance should be at the core of every communication with the public. Linked to this, they thought the public need to understand the rationale behind each policy change.
Two virtual dialogue workshops were conducted in June, and a further four virtual deliberative workshops: all six with the same 59 Londoners. Alongside the main workshops, we also conducted interviews and a sense-check workshop with advocates of vulnerable groups, and interviews with individuals experiencing barriers to accessing and using NHS services.
Trust and the reputation of the pharmaceutical industry: has the pandemic made a difference?
Since the global pandemic, the public have had more exposure to the power of pharma companies to improve and save lives. The sector has also been exposed to an unprecedented level of mainstream media coverage. So the big question is; has this has led to a heightened degree of trust?